Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis

Hyperglycemia-induced renal fibrosis causes end-stage renal disease. Clopidogrel, a platelet inhibitor, is often administered to decrease cardiovascular events in diabetic patients. We investigated whether clopidogrel can reduce diabetes-induced renal fibrosis in a streptozotocin-induced type 1 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zongyu, Ma, Tianjiao, Lian, Xin, Gao, Jialin, Wang, Weigang, Weng, Wenya, Lu, Xuemian, Sun, Weixia, Cheng, Yanli, Fu, Yaowen, Rane, Madhavi J., Gozal, Evelyne, Cai, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329922/
https://www.ncbi.nlm.nih.gov/pubmed/30662363
http://dx.doi.org/10.7150/ijbs.29063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329922/
https://www.ncbi.nlm.nih.gov/pubmed/30662363
http://dx.doi.org/10.7150/ijbs.29063

Ejemplares similares